Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
Journal of Neuro-Oncology · 2024
DOI: 10.1007/s11060-024-04668-5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Lucy Gately und 36 weiteren Autor:innen. Beteiligte Einrichtung: Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. lucy.gately@mh.org.au. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Spanish Institute Carlos III, Victorian Comprehensive Cancer Centre.
Abstract (Originalsprache)
PURPOSE: The impact of age on optimal management of glioblastoma remains unclear. A recent combined analysis of two randomised trials, GEINO14-01 and EX-TEM, found no benefit from extending post-radiation temozolomide in newly diagnosed glioblastoma. Here, we explore the impact of age. METHODS: Relevant intergroup statistics were used to identify differences in tumour, treatment and outcome characteristics based on age with elderly patients (EP) defined as age 65 years and over. Survival was estimated using the Kaplan Meier method. RESULTS: Of the combined 205 patients, 57 (28%) were EP. Of these, 95% were ECOG 0-1 and 65% underwent macroscopic resection compared with 97% and 61% of younger patients (YP) respectively. There were numerically less MGMT-methylated (56% vs. 63%, p = 0.4) and IDH-mutated (4% vs. 13%, p = 0.1) tumours in EP vs. YP. Following surgery, EP were more likely to receive short course chemoradiation (17.5% vs. 6%, p = 0.017). At recurrence, EP tended to receive or best supportive care (28.3% vs. 15.4%, p = 0.09) or non-surgical options (96.2% vs. 84.6%, p = 0.06), but were less likely to receive bevacizumab (23.1% vs. 49.5%, p < 0.01). Median PFS was similar at 9.3months in EP and 8.5months in YP, with similar median OS at 20months. CONCLUSION: In this trial population of predominantly fit EP, survival was similar to YP despite a proportion receiving less aggressive therapy at diagnosis and recurrence. Advancing age does not appear to be an adverse prognostic factor for glioblastoma when patients are fit for treatment, and a less aggressive approach in selected patients may not compromise outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. lucy.gately@mh.org.au.
- Department of Medical Oncology, Alfred Health, Prahran, VIC, Australia. lucy.gately@mh.org.au.
- Medical Oncology Service, Institut Català d'Oncologia, Hospitalet de Llobregat, Spain.
- Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Medical Oncology Service, Institut Català d'Oncologia Girona, Girona, Spain.
- Medical Oncology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
Förderung
- Spanish Institute Carlos III
- Victorian Comprehensive Cancer Centre
Zitieren
APA
Gately, L., Mesía, C., Sepúlveda, J. M., Del Barco, S., Pineda, E., Gironés, R., Fuster, J., Dumas, M., Gill, S., Navarro, L. M., Herrero, A., Dowling, A., de Las Peñas, R., Vaz, M. A., Alonso, M., Lwin, Z., Harrup, R., Peralta, S., Long, A., …, & Balana, C. (2024). Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM). Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04668-5
Vancouver
Gately L, Mesía C, Sepúlveda JM, Del Barco S, Pineda E, Gironés R, et al. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM). Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04668-5
BibTeX
@article{Gately2024,
author = {Gately, Lucy and Mesía, C and Sepúlveda, J M and Del Barco, S and Pineda, E and Gironés, R and Fuster, J and Dumas, M and Gill, S and Navarro, L M and Herrero, A and Dowling, A and de Las Peñas, R and Vaz, M A and Alonso, M and Lwin, Z and Harrup, R and Peralta, S and Long, A and Perez-Segura, P and Ahern, E and Garate, C O and Wong, M and Campbell, R and Cuff, K and Jennens, R and Gallego, O and Underhill, C and Martinez-Garcia, M and Covela, M and Cooper, A and Brown, S and Rosenthal, M and Torres, J and Collins, I M and Gibbs, P and Balana, C},
title = {Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)},
journal = {Journal of Neuro-Oncology},
year = {2024},
doi = {10.1007/s11060-024-04668-5}
}
EUVIMED